hims & hers fda warning letter compounded semaglutide 2025 and Novo Nordisk Warn of GLP-1 Telehealth Compounding Take Down – What's Next? Hims & Hers' Compounded Wegovy

At Skin Artisans, we believe that kind of transformation deserves to be celebrated

Medical weight loss is not a syringe and a slogan

Lillys oral GLP-1, orforglipron, demonstrated statistically significant efficacy results and a safety profile consistent with injectable GLP-1 medicines in successful Phase 3 trial

Understanding these differences helps set realistic expectations and avoid disappointment or confusion

Retatrutide 15mg and Reta 15mg Buy Retatrutide 15mg for advanced protocols

How to Safely Use Compounded Semaglutide Given the documented risks and recent FDA actions, patients using compounded semaglutide should take extra precautions: Essential Safety Steps: Work with your Care Team: Always obtain prescriptions from licensed healthcare providers familiar with GLP-1 medications Verify pharmacy credentials: Ensure the compounding pharmacy is state-licensed and preferably PCAB-accredited Request detailed information: Ask about ingredient sources, quality control processes, and batch testing Follow the medication guide: Carefully review all instructions for dosing and administration Monitor for adverse events: Report any unusual symptoms to your provider immediately Red Flags to Avoid: Online pharmacies advertising generic Ozempic or generic Wegovy (no generics exist) Products labeled for research purposes only Unusually low prices or no prescription required Lack of clear dosing instructions or concentration information Claims of oral tablets or nasal sprays (unproven delivery methods) Important Contraindications: Never use semaglutide if you have: Personal or family history of medullary thyroid carcinoma Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) History of diabetic retinopathy (requires monitoring) Severe kidney problems or gallbladder problems Pregnancy or planned pregnancy With the FDAs recent enforcement actions, finding legitimate sources for compounded semaglutide has become more challenging